Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Fecal Microbiota Transplantation (FMT) is a promising strategy that can reverse the intestinal dysbiosis associated with Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic dysfunction-associated fatty liver disease (MAFLD) (2). FMT is being actively explored as a gut–liver axis–targeted therapy in NAFLD, with early signals on microbiome, epigenetic and metabolic readouts, but clinical efficacy on hard liver endpoints remains preliminary and inconsistent. FMT application is potentially useful, but **it lacks randomized controlled trials t…